Credit Suisse’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History

Credit Suisse’s Portfolio BSX.PRA Stock Details BSX.PRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-20,000	Closed	-$2.42M	–	3315
2023 Q1	$2.42M	Sell	20,000 -100	-0.5%	-$11.5K	﹤0.01%	1756
2022 Q4	$2.31M	Hold	20,100	–	–	﹤0.01%	1789
2022 Q3	$2.03M	Hold	20,100	–	–	﹤0.01%	1849
2022 Q2	$2.04M	Buy	20,100 +100	+0.5%	+$10.9K	﹤0.01%	1895
2022 Q1	$2.33M	Hold	20,000	–	–	﹤0.01%	1975
2021 Q4	$2.29M	Buy	+20,000	New	+$2.28M	﹤0.01%	2690
2020 Q4	–	Sell	-5,000	Closed	-$559K	–	4484
2020 Q3	$559K	Hold	5,000	–	–	﹤0.01%	3323
2020 Q2	$523K	Buy	+5,000	New	+$536K	﹤0.01%	3304

Other funds holding BSX.PRA

LTI

Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return

Credit Suisse's BSX.PRA Position: Q2 2023 in Review

Credit Suisse sold out of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) in Q2 2023, closing a stake of 20,000 shares — an estimated $2.42M sold.

Credit Suisse first reported a position in BSX.PRA in Q2 2020 and held it in 8 quarters. The position peaked at $2.42M in Q1 2023. 1 fund tracked by Wall St. Rank holds BSX.PRA as of Q2 2023.

Credit Suisse reported no remaining Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position as of Q2 2023 after selling out during the quarter.
Credit Suisse sold 20,000 Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A shares in Q2 2023, an estimated $2.42M.
Credit Suisse first reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in Q2 2020 and held it in 8 quarters.
Credit Suisse's Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position peaked at $2.42M in Q1 2023.
1 fund tracked by Wall St. Rank held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A as of Q2 2023.

Based on Credit Suisse's 13F filing for Q2 2023, filed 11 Aug 2023.